Shopping Cart 0
Cart Subtotal
AED 0

Yale School of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 2753

Details

Summary

Yale School of Medicine (YSM), a subsidiary of Yale University is an educational service provider that offers bio-medical research, education and advanced health care. The center provides degree programs such as public health program, physician associate program, other PhD programs, medical degree program, nursing program, and others. It provides joint degrees with other Yale professional schools. The center offers research studies in the areas of epidemiology and public health, cell biology, biomedical engineering, comparative medicine, genetics, cellular and molecular physiology, and among others. It also provides patient care and clinical trial services. YSM is headquartered in New Haven, Connecticut, the US.

Yale School of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Yale School of Medicine, Medical Devices Deals, 2012 to YTD 2018 9

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Yale School of Medicine, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Immunomedics Enters into Research Agreement with Yale Cancer Center 11

Apexigen and Yale Cancer Center Enter into Clinical Collaboration Agreement 12

Patrys Enters into R&D Agreement with Yale School and Beth Israel Deaconess 13

Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 14

Organovo Enters into Co-Development Agreement with Yale School of Medicine 15

Licensing Agreements 16

NextCure Enters into Licensing Agreement with Yale School of Medicine 16

Yale School of Medicine-Key Competitors 17

Yale School of Medicine-Key Employees 18

Yale School of Medicine-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Government and Public Interest 21

Jul 11, 2018: A new gift will spur stem cell research 21

Apr 11, 2018: Study explores new strategy to develop a malaria vaccine 22

Mar 20, 2018: New Research Opens Door for Potential Treatment of Deadly Lung Disease 23

Feb 28, 2018: Genetic Sequencing in Heart Disease Patients Can Benefit Families 24

Oct 11, 2017: Forray study reveals potential new treatment for postpartum smokers 26

Jul 13, 2017: Heart Study Finds Faulty Link Between Biomarkers And Clinical Outcomes 27

Feb 14, 2017: Study points to potential new brain cancer treatment 28

Product News 29

Apr 16, 2018: Ketamine nasal spray found to have fast-acting effect on depression 29

Other Significant Developments 30

Jul 19, 2018: Complementary medicine for cancer can decrease survival 30

Jun 26, 2018: Human insulin as safe and effective to treat type 2 diabetes as costlier insulin analogs 31

Oct 17, 2017: Yale launches new program in addiction medicine 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Yale School of Medicine, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Yale School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yale School of Medicine, Deals By Therapy Area, 2012 to YTD 2018 8

Yale School of Medicine, Medical Devices Deals, 2012 to YTD 2018 9

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Immunomedics Enters into Research Agreement with Yale Cancer Center 11

Apexigen and Yale Cancer Center Enter into Clinical Collaboration Agreement 12

Patrys Enters into R&D Agreement with Yale School and Beth Israel Deaconess 13

Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 14

Organovo Enters into Co-Development Agreement with Yale School of Medicine 15

NextCure Enters into Licensing Agreement with Yale School of Medicine 16

Yale School of Medicine, Key Competitors 17

Yale School of Medicine, Key Employees 18

Yale School of Medicine, Subsidiaries 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Yale School of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Yale School of Medicine (YSM), a subsidiary of Yale University is an educational service provider that offers bio-medical research, education and advanced health care. The center provides degree programs such as public health program, physician associate program, other PhD programs, medical degree program, nursing program, and others. It provides joint degrees with other Yale professional schools. The center offers research studies in the areas of epidemiology and public health, cell biology, biomedical engineering, comparative medicine, genetics, cellular and molecular physiology, and among others. It also provides patient care and clinical trial services. YSM is headquartered in New Haven, Connecticut, the US.

Yale School of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Yale School of Medicine, Medical Devices Deals, 2012 to YTD 2018 9

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Yale School of Medicine, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

Immunomedics Enters into Research Agreement with Yale Cancer Center 11

Apexigen and Yale Cancer Center Enter into Clinical Collaboration Agreement 12

Patrys Enters into R&D Agreement with Yale School and Beth Israel Deaconess 13

Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 14

Organovo Enters into Co-Development Agreement with Yale School of Medicine 15

Licensing Agreements 16

NextCure Enters into Licensing Agreement with Yale School of Medicine 16

Yale School of Medicine-Key Competitors 17

Yale School of Medicine-Key Employees 18

Yale School of Medicine-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Recent Developments 21

Government and Public Interest 21

Jul 11, 2018: A new gift will spur stem cell research 21

Apr 11, 2018: Study explores new strategy to develop a malaria vaccine 22

Mar 20, 2018: New Research Opens Door for Potential Treatment of Deadly Lung Disease 23

Feb 28, 2018: Genetic Sequencing in Heart Disease Patients Can Benefit Families 24

Oct 11, 2017: Forray study reveals potential new treatment for postpartum smokers 26

Jul 13, 2017: Heart Study Finds Faulty Link Between Biomarkers And Clinical Outcomes 27

Feb 14, 2017: Study points to potential new brain cancer treatment 28

Product News 29

Apr 16, 2018: Ketamine nasal spray found to have fast-acting effect on depression 29

Other Significant Developments 30

Jul 19, 2018: Complementary medicine for cancer can decrease survival 30

Jun 26, 2018: Human insulin as safe and effective to treat type 2 diabetes as costlier insulin analogs 31

Oct 17, 2017: Yale launches new program in addiction medicine 32

Appendix 33

Methodology 33

About GlobalData 33

Contact Us 33

Disclaimer 33


List Of Figure

List of Figures

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Yale School of Medicine, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Yale School of Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Yale School of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Yale School of Medicine, Deals By Therapy Area, 2012 to YTD 2018 8

Yale School of Medicine, Medical Devices Deals, 2012 to YTD 2018 9

Yale School of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Immunomedics Enters into Research Agreement with Yale Cancer Center 11

Apexigen and Yale Cancer Center Enter into Clinical Collaboration Agreement 12

Patrys Enters into R&D Agreement with Yale School and Beth Israel Deaconess 13

Pierre Fabre Pharma Enters into Partnership with Yale School of Medicine 14

Organovo Enters into Co-Development Agreement with Yale School of Medicine 15

NextCure Enters into Licensing Agreement with Yale School of Medicine 16

Yale School of Medicine, Key Competitors 17

Yale School of Medicine, Key Employees 18

Yale School of Medicine, Subsidiaries 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Yale School of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.